Showing results (131-140 of 288) with videos related to
Sort By:
Pageof 29
Pharmaceutical Patent Analyst|September 10, 2016
Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic deliveryMarie Stark, R Holland ChengPharmaceutical Patent Analyst|July 12, 2017
A cheat sheet to navigate the complex maze of pharmaceutical exclusivities in EuropeMarta Cavero Tomas, Bo PengPharmaceutical Patent Analyst|July 2, 2020
Liposome-based drug delivery of various anticancer agents of synthetic and natural product origin: a patent overviewNaseem Akhtar, Salman Aa Mohammed, Varsha Singh, et al.Pharmaceutical Patent Analyst|April 9, 2015
Transient receptor potential ankyrin 1 (TRPA1) antagonistsDelia Preti, Giulia Saponaro, Arpad SzallasiPharmaceutical Patent Analyst|April 9, 2015
Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008-2014)Esther C Y Lee, Philip A CarpinoPharmaceutical Patent Analyst|November 10, 2022
4-(Imidazo[1,2-a]pyridin-3-yl): pyrimidine derivatives as anticancer agentsRami A Al-HoraniPharmaceutical Patent Analyst|November 11, 2022
Pyrrolidine derivatives as antibacterial agents, current status and future prospects: a patent reviewAeyaz A Bhat, Nitin Tandon, Runjhun TandonPharmaceutical Patent Analyst|July 22, 2025
Bispecific anti-CD38/CD28 antibodies for treatment of multiple myelomaMartin Perez-Santos, Maricruz Anaya-Ruiz, Donaciano Flores-Robles, et al.Pharmaceutical Patent Analyst|May 6, 2025
Patent spotlight on theranostics targeting fibroblast activation protein for personalized cancer careJason A Witek, Allen F Brooks, Benjamin L Viglianti, et al.Pharmaceutical Patent Analyst|November 16, 2022
Co-processed tablet excipient composition, its preparation and use: US10071059 B2: patent spotlightSajal Jain, Ritu Rathi, Upendra Nagaich, et al.Pageof 29